Our mission is to bridge the gap between scientific discovery and clinical application by 1) developing and optimizing promising therapies and 2) improving existing protocols, for the treatment of ...

It appears monthly, online and in print, and accepts contributions on spinal cord anatomy, physiology, management of injury and disease, and the quality of life and life circumstances of people ...

Believe it or not, your spinal cord may be a pathway to better mood and even an end to depression, new research suggests.

This designation supports the development of ExoPTEN and opens a pathway for faster entry into European markets, where the Company expects demand for effective spinal cord injury therapies to be high.